Coral Laboratories P/E Ratio
Current P/E Ratio
12.06
Low Valuation
Low - May indicate good value opportunity
Coral Laboratories (CORALAB) P/E ratio is 12.06 (Low), EPS (TTM) ₹45.85, current price ₹650.10 on BSE — Low - May indicate good value opportunity. Compare with CORALAB fair value to assess whether the stock is under or overvalued.
Current Valuation Metrics
P/E Ratio
12.06
Current Price
₹650.10
EPS (TTM)
₹45.85
Exchange
BSE
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
55.1
Sector Median
30.97
Sector Rank
#11 of 198
Sector Percentile
5.6%
CORALAB P/E Ratio — Valuation Signal & Historical Context
Coral Laboratories P/E 12.06 — signal: Fairly Valued. View CORALAB 52-week chart for the annual high/low range and current price position.
- Stock appears undervalued with PE of 12.06, suggesting potential buying opportunity
- Trading at discount to sector average PE of 55.1
CORALAB vs Healthcare Peers — P/E Ratio Comparison
Coral Laboratories P/E 12.06 vs Healthcare average 55.1, median 30.97 — range 2.86–706.0.
Sector Average
55.1
Sector Median
30.97
Lowest P/E
2.86
Highest P/E
706.0
Companies
198
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 2.98 | ₹52 | Low |
| Colinz Laboratories | COLINZ | 3.6 | ₹10 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.05 | ₹6,404 | Low |
| Sunrest Lifescience | SUNREST | 4.19 | ₹67 | Low |
| Shelter Pharma | SHELTER | 4.99 | ₹46 | Low |
| JFL Life Sciences | JFLLIFE | 5.83 | ₹78 | Low |
| GKB Ophthalmics | GKB | 5.94 | ₹33 | Low |
| Dipna Pharmachem | DPL | 6.52 | ₹18 | Low |
| Royal Sense | ROYAL | 6.73 | ₹48 | Low |